Rhumbline Advisers Raises Stake in Bio-Rad Laboratories, Inc. (NYSE:BIO)
Rhumbline Advisers grew its stake in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO – Free Report) by 1.7% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 55,410 shares of the medical research company’s stock after purchasing an additional 910 shares during the quarter. Rhumbline Advisers […]
Rhumbline Advisers grew its stake in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO – Free Report) by 1.7% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 55,410 shares of the medical research company’s stock after purchasing an additional 910 shares during the quarter. Rhumbline Advisers […]
